Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
DOI: 10.1093/neuonc/nox020
Arati S. Desai,
David Schiff,
Frank S. Lieberman,
Glenn J. Lesser,
Jeffrey G. Supko,
Jeffrey Leal,
Joy D. Fisher,
Louis B. Nabors,
Martin A. Lodge,
Matthias Holdhoff,
Richard L. Wahl,
Serena Desideri,
Stuart A. Grossman,
Tobias Walbert,
William L. Read,
Xiaobu Ye
Keywords: anaplastic glioma, glioblastoma, mibefradil, temozolomide, timed sequential therapy
Abstract:
Full-Text
